Comparison of pantoprazole- Vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population [2]
dc.authorscopusid | 6701920045 | |
dc.authorscopusid | 10039034400 | |
dc.authorscopusid | 6602895958 | |
dc.authorscopusid | 12545010100 | |
dc.authorscopusid | 6504632247 | |
dc.authorscopusid | 55396465200 | |
dc.authorscopusid | 12544770600 | |
dc.contributor.author | Alada? M. | |
dc.contributor.author | Kantarçeken B. | |
dc.contributor.author | Karincao?lu M. | |
dc.contributor.author | Sertkaya A. | |
dc.contributor.author | Çikim K. | |
dc.contributor.author | Harputluo?lu M.M.M. | |
dc.contributor.author | Demirel U. | |
dc.date.accessioned | 2024-08-04T20:01:02Z | |
dc.date.available | 2024-08-04T20:01:02Z | |
dc.date.issued | 2005 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.endpage | 243 | en_US |
dc.identifier.issn | 1300-4948 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 16547858 | en_US |
dc.identifier.scopus | 2-s2.0-33144461094 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 242 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/91220 | |
dc.identifier.volume | 16 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Turkish Journal of Gastroenterology | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | amoxicillin | en_US |
dc.subject | clarithromycin | en_US |
dc.subject | omeprazole | en_US |
dc.subject | pantoprazole | en_US |
dc.subject | bacterial infection | en_US |
dc.subject | clinical trial | en_US |
dc.subject | demography | en_US |
dc.subject | duodenum ulcer | en_US |
dc.subject | Helicobacter pylori | en_US |
dc.subject | human | en_US |
dc.subject | letter | en_US |
dc.subject | ulcer healing | en_US |
dc.subject | 2-Pyridinylmethylsulfinylbenzimidazoles | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Amoxicillin | en_US |
dc.subject | Anti-Bacterial Agents | en_US |
dc.subject | Anti-Ulcer Agents | en_US |
dc.subject | Clarithromycin | en_US |
dc.subject | Drug Therapy, Combination | en_US |
dc.subject | Duodenal Ulcer | en_US |
dc.subject | Female | en_US |
dc.subject | H(+)-K(+)-Exchanging ATPase | en_US |
dc.subject | Helicobacter Infections | en_US |
dc.subject | Helicobacter pylori | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Omeprazole | en_US |
dc.subject | Randomized Controlled Trials | en_US |
dc.subject | Randomized Controlled Trials as Topic | en_US |
dc.subject | Treatment Outcome | en_US |
dc.title | Comparison of pantoprazole- Vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population [2] | en_US |
dc.type | Letter | en_US |